Thalassaemia International Federation

What Thalassaemia International Federation does

Thalassaemia International Federation (TIF) is a non-profit patient federation founded in 1986 and headquartered in Nicosia, Cyprus, dedicated to thalassemia and related blood disorders. The organization operates as an international federation of national member associations, focusing on advocacy, education, and the dissemination of best practices for thalassemia prevention and management. TIF serves national healthcare systems, government health authorities, and patient advocacy communities, primarily in regions with high thalassemia carrier prevalence, and positions itself as a global thought leader through multi-country expert webinars and policy engagement.

The organization's primary activity is convening — organizing and co-hosting educational webinars, awareness campaigns, and research collaborations rather than building commercial products. Its most material technology-facing initiative is a strategic partnership with BGI Genomics (announced 2026-08-25) that leverages BGI's high-throughput next-generation sequencing capability for thalassemia variant detection to reduce misdiagnoses, with TIF participating in an international consortium aimed at expanding genomic screening across multiple countries. TIF does not develop the underlying sequencing technology itself; it functions as the federation, advocacy, and education layer that routes adoption into national health systems.

TIF's revenue model is consistent with a non-profit federation: funding is generated through membership fees, grants, and event sponsorships rather than direct product sales. Pricing is not publicly disclosed, and there are no disclosed funding rounds, acquisitions, or enterprise customers. The organization's small employee base (1-10) and lack of disclosed financial figures indicate a lean operational footprint scaled primarily through its member network and partner-led initiatives rather than internal commercial scaling.

Name

Thalassaemia International Federation

Website

https://thalassaemia.org.cy

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

1–10 employees

Short description

Thalassaemia International Federation is a non-profit patient federation founded in 1986 in Nicosia, Cyprus, dedicated to advocacy, education, and prevention of thalassemia through its international member network and partnerships with technology providers such as BGI Genomics.

Ownership category

akta.pro rank

Product category

Patient Advocacy and Disease Education

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

akta.pro secondary industry

Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

Keywords

• Patient advocacy
• Thalassaemia prevention
• Genetic screening education
• Blood disorder awareness
• Healthcare policy

Headquarters

HQ city

Nicosia

HQ country

Cyprus

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Educational Programs and Webinars: TIF organizes and co-hosts educational webinars on thalassemia prevention with technology partners. Revenue is likely generated through membership fees, grants, and sponsorships rather than direct product sales, as TIF is a patient federation organization.

Go-to-market motion2 records

Marketing channels1 record

Core offering

TIF is a non-profit federation founded in 1986 that delivers education, advocacy, and resources focused on thalassaemia and related blood disorders. It coordinates international educational webinars, awareness campaigns, and policy advocacy to improve thalassaemia prevention, screening, and patient care globally.

Product overview

Thalassaemia International Federation (TIF) is a healthcare advocacy and awareness organization focused on thalassemia prevention and management. TIF operates as a federation of national member organizations and collaborates with international partners including BGI Genomics on research initiatives, educational webinars, and awareness campaigns. The organization does not offer distinct software products, platforms, or technology offerings - its primary activities center on advocacy, knowledge sharing, and partnerships to advance global thalassemia prevention strategies.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Improved detection of thalassemia variants and reduced misdiagnoses

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• BGI GenomicscoreStrategic or Co-development Partner · 25 August 2026TIF and BGI Genomics co-hosted a webinar on thalassemia prevention featuring experts from four countries. The partnership leverages BGI's high-throughput sequencing technology and TIF's international federation network to improve thalassemia variant detection and reduce misdiagnoses globally. BGI is forming an international consortium in which TIF participates to apply these technologies across multiple countries.

Scale indicators2 records

Recent moves3 records

Expansion highlights3 records

Direct peers

• Cooley's Anemia Foundation: A US-based disease-specific nonprofit dedicated to thalassemia (Cooley's anemia) research, education, and patient advocacy. Directly comparable to TIF in mission, disease focus, and patient federation structure.
• European Haemoglobinopathy Association (EHA): A European scientific and medical organization focused on haemoglobinopathies including thalassemia. Highly comparable to TIF in disease focus, advocacy and educational mission, and engagement with national health systems.
• World Federation of Hemophilia: An international federation focused on bleeding disorders, structured similarly to TIF as a global network of national patient organizations. Comparable in federation model, advocacy and education focus, although targeting a different disease.
• Sickle Cell Disease Association of America: A US-based nonprofit advocacy and education organization for sickle cell disease, another inherited hemoglobin disorder. Comparable to TIF in disease category, patient federation model, and focus on genetic blood disorders.

Broad incumbents

• Genetic Alliance: A US-based nonprofit advocacy organization focused on genetic conditions and genetic health policy. Comparable to TIF in its engagement with genetic disease advocacy and policy, but operating at a broader disease and policy scope.
• Cystic Fibrosis Foundation: A large, well-funded disease-specific nonprofit driving research, advocacy, and care for cystic fibrosis. Comparable to TIF as a disease-specific nonprofit federation, but at a far larger scale and with a different disease.
• National Organization for Rare Disorders (NORD): A US-based umbrella organization for rare disease patient groups, including thalassemia organizations. Comparable as a disease-advocacy federation, though with a much broader mandate than TIF's thalassemia-specific focus.
• EURORDIS - Rare Diseases Europe: A larger European federation representing rare disease patient organizations, including thalassemia. Comparable in federation structure and advocacy model but operates across a much broader disease portfolio.
• American Cancer Society: A large disease-specific nonprofit focused on cancer research, education, and advocacy. Comparable in mission structure (disease-specific education and advocacy) but operates at vastly larger scale and scope than TIF.

Regional players

• Thalassemia Foundation of Canada: A Canadian national thalassemia patient and advocacy organization, with mission and activities directly comparable to TIF, but focused on the Canadian market rather than operating internationally.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/thalassaemia-international-federation-tif

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Thalassaemia International Federation